CD44 and non-small cell lung carcinoma: It has been shown that CD44+, and not CD44-, tumor cells sorted out from the primary mouse xenografts of non-small cell lung cancer (H1299) tumors exhibited shorter tumor latency in the subsequent tumor formations [121].